Skip to content

CalAmp CAMP Net margin

Net margin at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-30.9%-10.5pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-615.3%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,738.4%+1,407pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-166.4%-195pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
4.6%+2.4pp

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

Based on trailing twelve months.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's net margin?
CalAmp (CAMP) reported net margin of -2,193.7% in Q1 2026.
How has CalAmp's net margin changed year-over-year?
CalAmp's net margin increased by 36.0% year-over-year, from -3,428.3% to -2,193.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.